Sentro Pharma & Healthcare’s Post

🌟 Revolutionizing Cancer Treatment: The Future of Cell Therapies 🌟 Dive into the cutting-edge world of oncology with our latest insights on cell therapies. From CAR-T to NK cells, discover how these groundbreaking advancements are transforming cancer care, offering new hope and improved outcomes for patients worldwide. Stay informed on the latest trends and innovations that are setting new standards in medical treatment. For an in-depth exploration into the innovation trends shaping the future of cancer therapy, visit: https://lnkd.in/g9hAda5J #Oncology #CellTherapy #CancerTreatment #MedicalInnovation #NKCells #HealthCare #Research #CancerResearch #Patents #Pharma #LifeSciences #PrecisionMedicine #FutureOfMedicine #HealthcareInnovation #Biotech #Innovation #TTConsultants

Cancer persists as a global health challenge, demanding innovative approaches for early detection and treatment. #Biomarkers, as essential companions, offer insights into cancer risk, progression, and treatment efficacy. Delve into how biomarkers are transforming oncology, and discover the added benefits of MEDSIR in the pursuit of biomarker exploration. #PHERGain #Innovation #Research

Cyteph’s immunotherapy approach is unique in 🌟 Innovating Cancer Immunotherapy: Cyteph’s CMV-Specific T Cells therapies harness cytomegalovirus (CMV)-specific T cells. These cells naturally recognize and attack virus-infected cells, including cancer cells. Now unlike autologous therapies, they use allogeneic CMV-specific T cells from healthy donors. This allows for off-the-shelf treatments, eliminating individualized cell engineering. The manufacturing process ensures scalability. Allogeneic cells can be stored in a cell bank, ready for multiple patients. 🚀 #Immunotherapy #Biotech #Healthcare Cyteph’s is real groundbreaking work! 🙌🏼🔬 . When you look at the available CAR-T therapies (such as #YescartaTM, #KymriahTM, #BreyanziTM, #TecartusTM, #AbecmaTM, and #CarvyktiTM) for the treatment of B-cell malignancies this technology is in anew QALYs position with health technology assessment bodies (#HAS, G-BA, #NICE, and #SMC). leone beagley Sweera R. Pauline Santa QIMR Berghofer Medical Research InstituteRajiv Khanna, Rajiv Tyagi Fabienne Mackay Michael Finney, Nagaraj Gopisetty Ujjwal Dua https://lnkd.in/dUZEZh9b  

Anti-CD47 drug market This innovative class of therapies is gaining momentum for its potential to enhance cancer treatment by enabling the immune system to effectively target and destroy tumor cells. As research progresses, we're seeing promising clinical results and increasing investments in this area. Stay tuned as we explore the impact of these breakthroughs on patient outcomes and the future of oncology! Get more on: https://lnkd.in/d3Rq9Tjr #CancerResearch #Immunotherapy #HealthcareInnovation AntiCD47 #Immunotherapy #CancerTreatment #Oncology #PrecisionMedicine #Biotech #PharmaInnovation #ClinicalTrials #CancerResearch #TargetedTherapy #DrugDevelopment #HealthcareInnovation

📢 Revolutionary CAR-T Process Boosts Cancer Treatment Success! 🌟 A new CAR-T cell manufacturing process was presented at the ISCT 2024 meeting. 🧬 Researchers, led by Hélio Tomás, focused on key parameters affecting CAR-T cell characteristics. 💡 They used stirred-tank bioreactors to produce more effective CAR-T cells, especially for treating breast cancer. 🔥 This innovative method could enhance the efficacy of CAR-T therapies, potentially improving patient outcomes. #BioprocessUpdates #CAR-Tcells #CancerResearch #Biotechnology #ISCT2024 #CellTherapy #BreastCancer #InnovativeHealthcare #Bioreactors #MedicalAdvancements #PatientOutcomes #ManufacturingProcess #HélioTomás #CancerTreatment #CellManufacturing #TherapeuticInnovation ▷ Read the full article here: 📎 https://lnkd.in/dGegyWHa

Oncology Precision Medicine about advancing oncology through precision medicine, I believe in the transformative power of tailored treatments that align with individual patient profiles. By integrating genomic data and innovative #therapies, we can enhance #treatment efficacy and improve patient outcomes. I’m dedicated to collaborating with multidisciplinary teams to drive research and implementation of precision oncology solutions that empower patients in their fight against #cancer. Let's connect to explore the future of cancer care together Get more on : https://lnkd.in/dh3CHS4Z #PrecisionMedicine #Oncology #CancerResearch #PersonalizedMedicine #Genomics #TargetedTherapy #CancerCare #ClinicalTrials #Biomarkers #PatientCentric #HealthcareInnovation #CancerTreatment #Pharmacogenomics #CancerAwareness #FutureOfMedicine

🌟 𝐄𝐱𝐜𝐢𝐭𝐢𝐧𝐠 𝐧𝐞𝐰𝐬 𝐢𝐧 𝐜𝐚𝐧𝐜𝐞𝐫 𝐭𝐡𝐞𝐫𝐚𝐩𝐲! 🌟 Hybrid exosomes, a groundbreaking platform developed by Manash K. Paul, are set to revolutionize how we approach cancer treatment. Traditional methods struggle with effective drug delivery, but the 𝐢𝐧𝐧𝐨𝐯𝐚𝐭𝐢𝐯𝐞 𝐄𝐕-𝐥𝐢𝐩𝐨𝐬𝐨𝐦𝐞 𝐡𝐲𝐛𝐫𝐢𝐝𝐬 address these limitations, offering precise tumor imaging and tailored treatments. By harnessing the power of natural extracellular vesicles and artificial liposomes, we can enhance therapeutic efficiency and patient outcomes. Dive into this promising research and discover how these advancements can change the landscape of 𝐨𝐧𝐜𝐨𝐥𝐨𝐠𝐲! 👉 𝐋𝐞𝐚𝐫𝐧 𝐦𝐨𝐫𝐞: https://lnkd.in/gUhQSVGZ #CancerTherapy #HybridExosomes #Nanotechnology #InnovativeResearch #DrugDelivery #Oncology #Immunotherapy #Bioengineering #HealthcareInnovation #MedicalResearch #EVs #TumorImaging #Exosomes #Therapeutics #PrecisionMedicine

Current cancer screening methods are limited to imaging, with liquid biopsies only approved for colorectal screening. Breast and lung cancer screenings yield a high number of false positives, while colorectal tests involve invasive procedures. Recent recommendations to lower the screening age to 40 add pressure, especially in underserved areas. A simple and effective screening method is needed to test the recommended population. Definitive Diagnostics tested 273 patient blood samples for five cancers with a sensitivity of 99%, specificity of 97%, and a cancer tissue of origin accuracy of 98%. Our innovative biomarker patterns can also differentiate lung and ovarian cancer subtypes effectively. Our goal is to reduce false results by 90%. Watch our video to learn more. #Biomarker #sensitivity #specificity #TOO https://lnkd.in/ej-V9STs

It’s exciting to see the In Vitro Diagnostics market projected to hit $141.10 billion by 2030 in the Fortune Business Insights™. This growth isn’t just about numbers – it’s driving real innovation in oncology, where early detection and personalised treatments are making a difference in patients’ lives. Technologies like liquid biopsies, next-gen sequencing (NGS), and advanced biomarkers are reshaping how we diagnose and treat cancer, giving us tools to act faster and more precisely. As someone passionate about healthcare innovation, I’m excited about the possibilities ahead. This intersection of diagnostics and oncology is creating opportunities to truly personalise cancer care. How do you think we can continue making an impact? #Diagnostics #IVD #Oncology #HealthcareInnovation #CancerCare Source: https://lnkd.in/eCJBCNRT

Are biomarkers the key to diagnosing and treating cancer effectively? 🔑 They help identify patients who will benefit most from targeted therapies, making clinical trials faster and more efficient. However, reliable biomarkers are still lacking for many cancers. 🔎 At Parexel, our team of experts is leveraging diverse data streams and exciting advances in #AI and #machinelearning to fast-track cancer research and improve patient outcomes. We asked Angela Qu to describe how recent advances in multi-omics and computational analytics accelerate the discovery and validation of biomarkers in precision oncology. Read her responses at the link below! #Biomarkers #Oncology #PrecisionOncology #NovelInsights